Tune Therapeutics
Tune Therapeutics is a clinical-stage epigenetic editing biotechnology company headquartered in Durham, North Carolina with a second site in Seattle, Washington. Founded in 2021 by Charles Gersbach, Fyodor Urnov and Dan McHugh, the company develops its TEMPO platform for tunable epigenome editing — programmable DNA-binding modulation of gene expression that does not cut or permanently alter the underlying DNA sequence. Its lead program, TUNE-401, is an investigational epigenetic silencing therapy for chronic hepatitis B cleared by New Zealand Medsafe for a Phase 1b trial. Tune publishes no product API and operates no developer program; the only machine-readable surface it exposes is the WordPress REST API and a pair of OAuth-gated Model Context Protocol servers shipped by plugins on its corporate marketing site.
Tune Therapeutics publishes 1 API on the APIs.io network. Tagged areas include Company, Biotechnology, Life Sciences, Therapeutics, and Genomics.
Tune Therapeutics’ developer surface includes engineering blog, support, authentication, and 10 more developer resources.
Kin Score
APIs 1
Individual APIs this provider publishes, each with its own machine-readable definition.
Tune Therapeutics Website MCP Server
Two Model Context Protocol servers exposed from the Tune Therapeutics corporate WordPress site via the WordPress MCP Adapter plugin, backed by the WordPress Abilities API. Both ...
MCP Servers 1
Model Context Protocol servers that expose these APIs to AI agents.
tune-therapeutics-mcp.yml
MCP SERVERSecurity Posture 2
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Scopes 1
OAuth scopes governing access to this provider's APIs.
Resources
Agent Surfaces 3
MCP servers, agent skills, and machine-readable catalogs
Design & Contract 1
Pagination, idempotency, versioning, errors, and events
Access & Security 3
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 3
The organization behind the API